Whats New

COVID-19 Dash Board Compilation

Date Particulars
21-05-2020 Office Memorandum on N-95 Masks.
22-04-2020 NPPA recommendation for release for Export of Hydroxychloroquine and Paracetamol API/Formulations.
15-04-2020 NPPA recommendation for release for Export of Paracetamol API/Formulations.
15-04-2020 NPPA recommendation for release for Export of Hydroxychloroquine API/Formulations
17-04-2020 Amendment in Export Policy of formulations made from Paracetamol (including FDCs)
06-04-2020 Amendment in Export Policy of APIs and formulations made from these APIs
04-04-2020 Amendment in Export Policy of Diagnostic Kits.
04-04-2020 Amendment in Export Policy of Hydroxychloroquine.
25-02-2020 Amendment in Export Policy of Personal Protection Equipments/Masks
08-02-2020 Amendment in Export Policy of Personal Protection Equipment / Masks
31-01-2020 Amendment in Export Policy of Personal Protection Equipment / Masks
20-04-2020 Helpline numbers for availability of Hydroxychloroquine
06-04-2020 The Government delegates powers of Para 3 of the DPCO, 2013 to NPPA vide Notification No. S.O. 1249(E) dated 06th April 2020
01-04-2020 NPPA writes to all Chief Secretaries of States/UTs to ensure availability of Medical Equipments such as PPE, Masks, Gloves, Testing Kits and Ventilators
31-03-2020 A Notification issued regarding Medical Devices governance under DPCO, 2013
30-03-2020 NPPA writes to all SDCs to provide information regarding status of pharma production units functioning the States
27-03-2020 NPPA directed companies concerned to submit data w.r.t Lopinavir, Ritonavir, Hydroxycholoquine, Azithromycin and Paracetamol by merchant importers/stockiest/ manufacturers of APIs/ formulations in the country
26-03-2020 NPPA issued advisory for manufacturers/marketers of drugs/medicines/medical devices regarding precaution to be taken by manufacturers during COVID-19 outbreak
26-03-2020 NPPA writes to all Chief Secretaries of States/UTs to ensure unobstructed movement of raw material, packing material, finished products and manpower related to manufacturing and distribution of drugs and medical devices
26-03-2020 NPPA has issued Order to companies concerned to maintain sufficient stock level of ‘Lopinavir & Ritonavir’ at any point of time to ensure availability of medicines.
25-03-2020 Directorate General of Foreign Trade banned Export of All Ventilators including any artificial respiratory apparatus or oxygen therapy apparatus or any other breathing appliance/device
25-03-2020 Directorate General of Foreign Trade banned Export of (i) Hydroxychloroquine and (ii)  Formulations made from Hydroxychloroquine
24-03-2020 Ministry of Consumer Affairs, Food and Public Distribution, Government of India fixes/regulates the Prices of 3 ply Masks containing a layer of Melt Blown non-Woven Fabric for a period up to 30th June 2020.
21-03-2020 Ministry of Consumer Affairs, Food and Public Distribution, Government of India fixes/regulates the Prices of Masks (2/3 Ply) and Hand Sanitizers for a period up to 30th June 2020
19-03-2020 Ministry of Consumer Affairs, Food and Public Distribution, Government of India writes to Chief Secretaries of all the States/UTs to enhance production of Hand Sanitizers and to ensure availability to the consumers
19-03-2020 In order to encourage R&D of IVD Kits for diagnosis of COVID-19, Drug Controller General (India) eased the process of providing guidance on regulatory pathway for IVD Kits
19-03-2020 At the intervention of NPPA, Directorate General of Foreign Trade prohibited Exports of Surgical/Disposable Masks (2/3 Ply), all Ventilators and Textile raw materials for Masks and Coverall
19-03-2020 At the intervention of NPPA, Drug Controller General (India) directed his Port Offices to take necessary proactive measures to help for clearance of imported stocks of Gloves in coordination with Customs in expedited manner in public interest
19-03-2020 On the written request of Industry Association, NPPA writes to Secretary (Textile) for temporary Export restriction on critical inputs for Masks
18-03-2020 NPPA issued an O.M. directing companies to submit price related data in respect of Surgical & Protective Masks
18-03-2020 NPPA writes to all Drug Controllers of all States/UTs to take immediate action through field Officers to restrain acts of hoarding and profiteering by manufacturers, distributors, stockist and retailers and also ensure availability and essential items at prices not more than MRP
17-03-2020 Drug Controller General (India) writes to Drug Controllers of all the States/UTs to expedite the licensing process for manufacturers of Hand Sanitizers by taking proactive measures to meet the present challenges of increased demand of such product in the country
17-03-2020 NPPA issued reminder regarding submission of requisite data in respect of O.M. dated 13th March 2020
16-03-2020 NPPA organized a Meeting with AiMeD, Mask, Gloves & Sanitizer Associations and Chemist & Druggist Association under the chairmanship of Chairman, NPPA
13-03-2020 NPPA issued an O.M. directing companies to submit data in respect of Surgical & Protective Masks, Gloves and Hand Sanitizers
13-03-2020 NPPA invokes the powers delegated under Disaster Management Act, 2005 and issued an Order directing Chief Secretaries of all the Sate/UTs to ensure prevention of hoarding, black marketing and profiteering of essential commodities.
13-03-2020 Ministry of Consumer Affairs, Food and Public Distribution, Government of India has notified Masks (2 Ply & 3 Ply Surgical Masks, N95 Masks) and Hand Sanitizers as essential commodities under Essential Commodities Act, 1955
13-03-2020 Ministry of Health & Family Welfare, Government of India vide its Order No. X.11035/136/2020-DR dated 13th March 2020 had directed National Pharmaceutical Pricing Authority (NPPA) under clause (l) of sub-section (2) of section 10 of Disaster Management Act, 2005 to take all necessary steps to immediately regulate the availability and prices of (i) Surgical and protective Masks (ii) Hand Sanitizer and (iii) Gloves.
11-03-2020 Ministry of Home Affairs, Government of India vide its Order No. F. No. 40-2/2020-DM-I(A) dated 11th March 2020 had delegated its power under clauses (i) and (l) of sub-section (2) of Section 10 of the Disaster Management Act, 2005 to the Ministry of Health & Family Welfare, Government of India.
06-03-2020 NPPA issued reminder regarding submission of requisite data in respect of O.M. dated 26th February 2020
03-03-2020 DGFT restricts exports of 13 API and formulations made using these APIs. These APIs are primarily made in Hubei province of China.
26-02-2020 NPPA directed companies concerned to submit data w.r.t select APIs by merchant importers/stockiest/ manufacturers of APIs/ formulations in the country
20-02-2020 NPPA writes to all Chief Secretaries of States/UTs to closely monitor availability of APIs and drugs in context of outbreak of COVID-19 in China
06-02-2020 Department of Pharmaceuticals has constituted a Committee under the chairmanship of Dr. Eshwara Reddy, Joint Drugs Controller, Central Drugs Standard Control Organization (CDSCO) to address the issues of drug security in the country in the context of Novel Coronavirus outbreak in China.